SCHEMBL724944

SCHEMBL724944

C=C(C(=O)N(C)C)C(N)CC

nearest known ligand 0.33

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.33
SLC1A2 P43004 1/20 0.33
SLC1A1 P43005 1/20 0.33
LAP3 P28838 1/20 0.33
GRIK1 P39086 1/20 0.30
GRIK2 Q13002 1/20 0.30
GRM1 Q13255 1/20 0.30
GRM2 Q14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21625956 0.76
SCHEMBL7053012 0.76
SCHEMBL639213 0.75
SCHEMBL1063165 0.75 SLC7A5 (0.35)
SCHEMBL1275232 0.75
Hydrochloric Acid SCHEMBL23388744 0.73 GRIK1 (0.41) SLC1A3SLC1A2SLC1A1LAP3GRIK1
Hydrochloric Acid SCHEMBL6055075 0.73 TDP1 (0.38) SLC1A3SLC1A2SLC1A1LAP3GRIK1
SCHEMBL1189930 0.72
SCHEMBL25673513 0.72
SCHEMBL2929108 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200239680-A1 INTERPENETRATING POLYMER NETWORK CONTAINING CROSS-LINKED POLY(N-VINYLAMINE) KEMIRA OYJ (FI) 2020-07-30 US claimed
EP-2321235-B1 USE OF A PLASTICIZER-CONTAINING HARDENING ACCELERATOR COMPOSITION CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2019-03-20 EP claimed
EP-2664596-B1 Process for preparing a plasticizer-containing hardening accelerator composition CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2018-11-21 EP claimed
EP-3344815-A1 INTERPENETRATING POLYMER NETWORK CONTAINING CROSS-LINKED POLY(N-VINYLAMINE) Kemira OYJ (FI) 2018-07-11 EP claimed
EP-2664596-A2 Plasticizer-containing hardening accelerator composition Construction Research & Technology GmbH (DE) 2013-11-20 EP claimed
EP-2664595-A2 Plasticizer-containing hardening accelerator composition Construction Research & Technology GmbH (DE) 2013-11-20 EP claimed
EP-2383261-B1 Process for the asymmetric hydrogenation of ketones EUTICALS GMBH (DE) 2013-09-04 EP claimed
EP-2321235-A1 PLASTICIZER-CONTAINING HARDENING ACCELERATOR COMPOSITION Construction Research & Technology GmbH (DE) 2011-05-18 EP claimed
US-20110095227-A1 RETARDED SUPERABSORBENT POLYMERS CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2011-04-28 US claimed
US-7863388-B2 Preparation of functionalized cationic polymers and their application in personal care BASF SE (DE) 2011-01-04 US claimed
WO-2010026155-A1 PLASTICIZER-CONTAINING HARDENING ACCELERATOR COMPOSITION CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2010-03-11 WO claimed
US-7338608-B2 Solid-liquid separation of oil-based muds KEMIRA OYJ (FI) 2008-03-04 US claimed
US-20070185281-A1 Preparation of functionalized cationic polymers & their application in personal care BASF SE (DE) 2007-08-09 US claimed
US-6432894-B1 SHAMPOO MIXTURE L'OREAL (FR) 2002-08-13 US claimed
US-5173160-A ANALYSIS OF CARRIER AMPHOLYTES USING IMMOBILIZED PH GRADIENTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1992-12-22 US claimed
WO-1992015870-A1 ANALYSIS OF CARRIER AMPHOLYTES USING IMMOBILIZED PH GRADIENTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1992-09-17 WO claimed
JP-8327821-A None JP disclosed
US-12610770-B2 Substrate processing system and substrate processing method SCREEN Holdings Co., Ltd. (JP) 2026-04-21 US disclosed
EP-0234430-A2 Diluent for UV and EB curable resins Kohjin Co., Ltd. (JP) 1987-09-02 EP disclosed
EP-0161882-A2 Adsorption-desorption method for the separation of water soluble organic compounds from aqueous solution MITSUI TOATSU CHEMICALS, Inc. (JP) 1985-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12610770-B2 Substrate processing system and substrate processing method STUB1, SENP1, CLPP SLC1A3 1496/4885SLC1A2 1516/4885SLC1A1 2216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.